Masterclass session addresses looking beyond a dashboard by added capabilities with added value.
Day 1 of LogiPharma Europe from Lyon, France had seen its share of captivating presentations, including a masterclass session regarding supply chain efficiencies.
Titled “Not another dashboard! How to infuse pulse into your supply chain operation” and led by Hadi Rizek, Netcompany’s head of supply chain and manufacturing, alongside Krzysztof Gajda, the company’s product manager for supply chain execution, Michael Kilchherr, Roche’s business capability manager, global product and supply chain management, the session expressed the importance of moving beyond visibility and towards value-added capabilities.
Rizek noted that establishing visibility is certainly a major milestone, and many organizations struggle in the first place to get there. Currently, we are living in a fragmented data and system landscape, with visibility running through what is known as a unified data model; establishing situational awareness across the model is paramount.
However, he added that visibility along does not add any value. Rather, he recommended that value-added capabilities be leveraged as a next step.
This involved an order and management inventory management process that features:
In a value-added use case, Kilchherr expressed his opinion that dashboards are not enough for three main reasons:
Roche believes in the importance of reducing interfaces and enabling management by exception, which consists of going from a high number of interfaces and handovers among roles in the operational planning and order fulfillment roles, to empowered roles that are able to more “seamlessly” connecting markets and packaging sites in a manner that helps them adapt to change quickly.
Reference
Rizek, H, Austin L, Gajda K, Kilchherr, M.Not another dashboard! How to infuse pulse into your supply chain operation. April 16, 2024. LogiPharma Europe 2024. Lyon.
Specialty Pharmacy: The Trends Shaping Best Practices
October 2nd 2024When it comes to navigating the complex clinical and commercial landscape for specialty drugs—including hurdles in access to these critical but costly therapies—today’s specialty pharmacies are bringing more skills and services to the table.